DCGI BE-NOC [Regulatives / Guidelines]

posted by drgunasakaran1  – 2012-02-03 14:19 (5243 d 13:21 ago) – Posting: # 8050
Views: 5,936

(edited on 2012-02-03 18:52)

Dear Mr.Rave,

If the drugs are approved in the 2007 and the drug is available in the Indian market for more than 04 years, then there is no need for BE NOC. However, you may need to apply for T License if your are planning to import the investigational product from foreign countries in case if your are planing to conduct the above two studies for USFDA/EMEA/other foreign regulatory bodies.

❝ Rest two are Levonorgestrel 0.15mg + Ethinylestradiol 0.03mg FDC & Levonorgestrel 0.75 mg but we are manufacturing them for more than 4 years. please help!!!


Levonorgestrel 0.15mg + Ethinylestradiol 0.03mg FDC was approved by CDSCO on 13.10.10.
Ref: http://cdsco.nic.in/LIST%20OF%20APPROVED%20DRUG%20FROM%2001.htm


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
140 visitors (0 registered, 140 guests [including 26 identified bots]).
Forum time: 04:40 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5